Back to news

Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury

PR Newswire•17/11/2026•16:30 ET
0

Key Highlights

  • ➤Labcorp (LH) collaborates with Grupo Fleury to expand clinical trial operations in Brazil
  • ➤Local clinical trial kit assembly expected to begin in early 2027
  • ➤Laboratory operations in Brazil expected to launch by the end of 2027
  • ➤Expansion aims to shorten kit delivery times and reduce international shipping reliance

Expert Statements

Brian Caveney, President, biopharma laboratory services and chief medical and scientific officer, Labcorp

“Clinical trials today often span multiple countries, and sponsors need partners that can combine global expertise with local insight”

Brian Caveney, President, biopharma laboratory services and chief medical and scientific officer, Labcorp

“Our expansion in Brazil reflects the country's growing role in global clinical research while maintaining the high standards and consistency sponsors expect across global studies.”

Edgar Rizzatti, President of Grupo Fleury's Medical, Technical, Hospitals, New Links and Innovation Business Unit

“Brazil continues to strengthen its position in global clinical research, supported by a diverse patient population, strong scientific capabilities and experienced research teams”

Edgar Rizzatti, President of Grupo Fleury's Medical, Technical, Hospitals, New Links and Innovation Business Unit

“By combining Grupo Fleury's scientific expertise, operational excellence and deep understanding of the local research environment with Labcorp's global clinical trial capabilities, we can help make clinical trials more efficient, broaden access to research opportunities and support the continued development of Brazil's clinical research ecosystem.”

Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury PR Newswire

Expansion will bring clinical trial services closer to research sites and patients while supporting global studies

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in